Clin2
NCT07633119Possibly a fitNot yet recruiting

Study of an injection to prevent tetanus after high-risk exposure

Tetanus

Part of Infections clinical trials.

This study tests an injection that may help prevent tetanus in people who have had a high-risk exposure, like a deep or dirty wound. It aims to see if the injection is safe and effective for protecting against tetanus.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
600 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be 18 years old or older.
  • You must have had a high-risk tetanus exposure, such as a wound that could be contaminated with tetanus bacteria.
  • You must be able to understand and sign a consent form agreeing to participate.
  • If you or your partner can have children, you must agree to use effective birth control for 6 months after the injection and not donate sperm or eggs.
  • You cannot have had tetanus before or be suspected of having it now.
  • You cannot have had 3 or more doses of tetanus vaccine in the past, or if fewer than 3 doses, your last dose must have been more than 6 months ago.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07149454Enrolling by invitation· Phase 1
Testing a new antibody to prevent tetanus

This trial tests a new medicine made from antibodies that target tetanus toxin. It may help protect people from tetanus without needing a vaccine.

Lanzhou, Gansu
NCT07347938Recruiting
Tetanus prevention after injury: study of siltartoxatug

This study compares a new tetanus shot (siltartoxatug) with standard tetanus treatments to see if it works as well. It is for people aged 18 and older who need tetanus protection after an injury.

Hangzhou, Zhejiang
NCT07107932Recruiting
Registry for Tetanus Prevention After Injury

This registry collects information on people who receive the study drug Siltartoxatug to prevent tetanus after an injury. It helps researchers learn more about how the drug works in real-world use.

Shantou, Guangdong
NCT07807033Not yet recruiting
Long-term immune response check after tetanus vaccine

This study checks how long your body's protection from the tetanus vaccine lasts. It follows up with people who already got the vaccine in an earlier study to see if their immunity is still strong years later.

Bijie, Guizhou
NCT07624669Not yet recruiting· Phase 4
Tetanus vaccine patch study in healthy adults

This study tests a new microneedle patch that delivers a tetanus booster vaccine through tiny needles in the skin, without a traditional shot. The patch is applied to the forearm, and the study checks its safety and how the body responds.

NCT07446166Not yet recruiting
Testing tetanus antibodies in saliva

This study checks if a simple saliva test can detect tetanus protection, which could replace blood tests. It includes healthy children, young adults, pregnant women, and adults with certain health conditions.

Kigali

Hear when a new Tetanus trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.